Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ashish Nanda

Vascular Neurology Fullerton, CA Medical Doctor

NPI 1598980518 CMS profile 163220

101 E Valencia Mesa Dr, Fullerton, CA 92835

Open in the dashboard

General payments

$65,787

193 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$271,525 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Ashish Nanda of Fullerton, CA is reported in the CMS Open Payments database as having received $65,787 across 193 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $271,525 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Vascular Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $624 13
2024 General $33,359 44
2023 General $12,899 25
2022 General $6,905 35
2021 General $2,401 25
2020 General $7,453 21
2019 General $2,146 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ashish Nanda
  • Vascular Neurology median
  • Middle half of Vascular Neurology
  • National median

In program year 2025, general payments to Ashish Nanda were reported at $624. Among 416 Vascular Neurology profiles paid that year, the median was $360 and the middle half received between $91 and $1,472.

Show as a table
Year Ashish Nanda Vascular Neurology median Middle half National median
2019 $2,146 $263 $102–$1,640 $163
2020 $7,453 $153 $45–$1,000 $114
2021 $2,401 $261 $100–$1,355 $132
2022 $6,905 $242 $87–$1,273 $149
2023 $12,899 $322 $97–$1,266 $160
2024 $33,359 $247 $70–$1,053 $164
2025 $624 $360 $91–$1,472 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Penumbra, Inc. $50,518 137 payments
  2. Medical Device Business Services, Inc. $11,384 5 payments
  3. DePuy Synthes Sales Inc. $1,315 14 payments
  4. Stryker Corporation $1,305 18 payments
  5. Medtronic, Inc. $339 4 payments
  6. Imperative Care, INc $226 3 payments
  7. Access Pro Medical, LLC $190 2 payments
  8. Scientia Vascular $181 2 payments
  9. Acera Surgical, Inc. $148 1 payment
  10. Medtronic USA, Inc. $83 2 payments
  11. Other $99 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $39,376 10 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,300 6 payments
  3. Food and Beverage $10,071 161 payments
  4. Travel and Lodging $4,040 16 payments
Products named General payments · program years 2019–2025
  1. Penumbra System Neurointervention $38,474 57 payments
  2. Penumbra System Neurointervention $9,830 24 payments
  3. TRUFILL $7,614 8 payments
  4. EMBOTRAP $7,394 5 payments
  5. CEREPAK UNIFORM $7,275 3 payments
  6. Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device $7,275 3 payments
  7. EMBOGUARD $4,234 3 payments
  8. Smart Coil $1,480 8 payments
  9. Penumbra Coil 400 $1,177 20 payments
  10. TARGET $586 7 payments
  11. Other $4,801 82 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$70,438

Medicare's payments for the services billed

Medicare patients

67

Average age 80

Services billed

334

35 women, 32 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 51%
Heart failure 51%
Ischemic heart disease 51%
Chronic kidney disease 51%
Atrial fibrillation 42%
Arthritis 42%
Alzheimer's or dementia 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

193 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Neurology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record